We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

PDL Grants Patent Licenses to Merck for Humanized Antibodies

The licensing of humanized antibody technology will build a commercial operation focused on the acute care hospital setting.
News

Nutra Pharma Reports Discovery of Gene Involved in Multiple Sclerosis

The research provides evidence that RPI-78M modulates the expression of this gene in laboratory assays.
News

Morphotek Expands Oncology Pipeline with Product Candidate from NCI

Morphotek is applying its antibody technologies to develop and optimize antibodies to cancer-associated proteins.
News

Genmab Appoints Annarie Lyles as Head of Business Development

Dr. Lyles replaces Dr. Ernst Schweizer, remains a member of the Genmab Board of Directors.
News

Fogarty Announces Awards for Biodiversity-Based Drug Discovery Research

Compounds from natural products continue to be the important sources of completely new chemistry.
News

ACD/Labs Opens new Office in the UK

The new office in the UK will serve local pharmaceutical, chemical, environmental, and academic markets.
News

Pfizer and Perlegen Form Genetics Research Collaboration

Researchers from both companies will conduct whole genome studies involving DNA samples from clinical trials.
News

Dharmacon and MIT Settle RNAi License Dispute

MIT has dismissed all of its legal claims against Dharmacon and its parent company Fisher Scientific International Inc.
News

Affymetrix and Vita Collaborate to Develop Microarray-based IVD Products

Vita Genomics is able to incorporate Affymetrix' patented arrays into its molecular diagnostic assays.
News

Gene Therapy for Muscular Dystrophy Fixes Frail Muscle Cells in Animal Model

Researchers used gene therapy to introduce a healthy copy of the gene dystrophin into mice with a condition that mimics muscular dystrophy.
Advertisement